Journal of Chinese Integrative Medicine ›› 2006, Vol. 4 ›› Issue (2): 160-165.doi: 10.3736/jcim20060211
• Original Experimental Research • Previous Articles Next Articles
Meng-chang Wang1, Shan-xi Liu1, Peng-bo Liu2
CLC Number:
[1] | Dalton WS . Targeting the mitochondria: an exciting new approach to myeloma therapy[J]. Clin Cancer Res, 2002,8(12):3643-3645 |
[2] | Amadori S, Fenaux P, Ludwig H , et al. Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent[J]. Curr Med Res Opin, 2005,21(3):403-411 |
[3] |
Matsuda S, Rouault J, Magaud J , et al. In search of a function for the TIS21/PC3/BTG1/TOB family[J]. FEBS Lett, 2001,497(2-3):67-72
doi: 10.1016/S0014-5793(01)02436-X pmid: 11377414 |
[4] | Prevot D, Voeltzel T, Birot AM , et al. The leukemia-associated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation[J]. J Biol Chem, 2000,275(1):147-153 |
[5] | Lin WJ, Gary JD, Yang MC , et al. The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase[J]. J Biol Chem, 1996,271(25):15034-15044 |
[6] |
Iwai K, Hirata K, Ishida T , et al. An anti-proliferative gene BTG1 regulates angiogenesis in vitro[J]. Biochem Biophys Res Commun, 2004,316(3):628-635
doi: 10.1016/j.bbrc.2004.02.095 pmid: 15033446 |
[7] |
Seet LF, Hong W . Endofin, an endosomal FYVE domain protein[J]. J Biol Chem, 2001,276(45):42445-42454
doi: 10.1074/jbc.M105917200 pmid: 11546807 |
[8] |
Seet LF, Liu N, Hanson BJ , et al. Endofin recruits TOM1 to endoscomes[J]. J Biol Chem, 2004,279(6):4670-4679
doi: 10.1074/jbc.M311228200 pmid: 14613930 |
[9] |
Seet LF, Hong W . Endofin recruits clathrin to early endosomes via TOM1[J]. J Cell Sci, 2005,118(Pt 3):575-587
doi: 10.1242/jcs.01628 pmid: 15657082 |
[10] | Iwabuchi K, Li B, Massa HF , et al. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2[J]. J Biol Chem, 1998,273(40):26061-26068 |
[11] | Goumans MJ, Valdimarsdottir G, Itoh S , et al. Activin receptor-like kinase(ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling[J]. Mol Cell, 2003,12(4):817-828 |
[12] |
Sugawara K, Sugawara I, Sukegawa J , et al. Distribution of C-yes-1 gene product in various cells and tissues[J]. Br J Cancer, 1991,63(4):508-513
doi: 10.1038/bjc.1991.121 pmid: 18507 |
[13] | Hui TY, Sheth SS, Diffley JM , et al. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals[J]. J Biol Chem, 2004,279(23):24387-24393 |
[14] | Jia P, Chen G, Huang X , et al. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3[J]. Chin Med J (Engl), 2001,114(1):19-24 |
[1] | Ya-hui Liang , Ping Li, Jing-xia Zhao, Xin Liu, Qi-fu Huang. Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1. Journal of Chinese Integrative Medicine, 2010, 8(11): 1060-1069. |
[2] | Shuang-nian Xu , Jie-ping Chen, Jian-ping Liu, Yun Xia . Efficacy of arsenic trioxide for acute promyelocytic leukemia: A systematic review and meta-analysis. Journal of Chinese Integrative Medicine, 2009, 7(9): 801-808. |
[3] | Shuang-nian Xu, Jie-ping Chen, Jian-ping Liu, Yun Xia. Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: A systematic review and meta-analysis. Journal of Chinese Integrative Medicine, 2009, 7(11): 1023-1034. |